Literature DB >> 8418034

Effects of cytokines on intracellular growth of Brucella abortus.

X Jiang1, C L Baldwin.   

Abstract

Interleukin 1 alpha (IL-1 alpha), IL-2, IL-4, IL-6, gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and granulocyte macrophage colony-stimulating factor (GM-CSF) were tested for their abilities to alter the growth of Brucella abortus in BALB/c J774A.1 murine macrophages. IL-1 alpha, IL-4, IL-6, tumor necrosis factor alpha, and granulocyte macrophage-colony-stimulating factor had no consistent or significant effect on the growth of the avirulent B. abortus strain 19. In contrast, the addition of either IFN-gamma or IL-2 at 100 U/ml to the macrophage cultures resulted in a significant reduction in the number of intracellular bacteria that was not attributable to decreased infection rates. With IL-2, the reduction was most often apparent only during the first 24 h after infection, while inhibition with IFN-gamma was apparent throughout the culture period of 48 h. The addition of either IL-2 or IFN-gamma to macrophage cultures also resulted in reduced intracellular CFU of the virulent B. abortus strain 2308 and the attenuated rough mutant B. abortus strain RB51. Inhibition of intracellular growth was not augmented by combinations of cytokines. Additional studies with IFN-gamma and IL-2 indicated that they could mediate the inhibition of intracellular growth of B. abortus in resident and thioglycolate broth-induced BALB/c peritoneal macrophages and in splenic macrophages. IFN-gamma also inhibited bacterial growth when added after infection of the macrophages, although the magnitude of the antibrucellae effects was less than that when it was added before infection. Furthermore, the maximal inhibitory effect was sustained only when IFN-gamma remained in the cultures after infection of the macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418034      PMCID: PMC302696          DOI: 10.1128/iai.61.1.124-134.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.

Authors:  M Belosevic; C E Davis; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

2.  Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.

Authors:  L Chen; Y Suzuki; E F Wheelock
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

3.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

Authors:  D J Stuehr; M A Marletta
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

4.  Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity.

Authors:  S M Wahl; N McCartney-Francis; D A Hunt; P D Smith; L M Wahl; I M Katona
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

5.  Survival of rough and smooth strains of Brucella abortus in bovine mammary gland macrophages.

Authors:  B G Harmon; L G Adams; M Frey
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

6.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

7.  Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

8.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.

Authors:  L E Bermudez; L S Young
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.

Authors:  S Heidenreich; M Weyers; J H Gong; H Sprenger; M Nain; D Gemsa
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

10.  Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.

Authors:  S G Reed; C F Nathan; D L Pihl; P Rodricks; K Shanebeck; P J Conlon; K H Grabstein
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  79 in total

1.  Regulation of Brucella abortus catalase.

Authors:  J A Kim; Z Sha; J E Mayfield
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice.

Authors:  Paolo Pasquali; Rosanna Adone; Louis C Gasbarre; Claudia Pistoia; Franco Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

3.  The siderophore 2,3-dihydroxybenzoic acid is not required for virulence of Brucella abortus in BALB/c mice.

Authors:  B H Bellaire; P H Elzer; C L Baldwin; R M Roop
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains.

Authors:  J Sathiyaseelan; X Jiang; C L Baldwin
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.

Authors:  Deyan Luo; Bing Ni; Peng Li; Wei Shi; Songle Zhang; Yue Han; Liwei Mao; Yangdong He; Yuzhang Wu; Xiliang Wang
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

Authors:  S Segura; C Gamazo; J M Irache; S Espuelas
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

7.  Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice.

Authors:  Wenpeng Gu; Xin Wang; Haiyan Qiu; Buyun Cui; Shiwen Zhao; Han Zheng; Yuchun Xiao; Junrong Liang; Ran Duan; Huaiqi Jing
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.

Authors:  E Caron; T Peyrard; S Köhler; S Cabane; J P Liautard; J Dornand
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51.

Authors:  R Vemulapalli; A J Duncan; S M Boyle; N Sriranganathan; T E Toth; G G Schurig
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.

Authors:  Isabelle Danese; Valerie Haine; Rose-May Delrue; Anne Tibor; Pascal Lestrate; Olivier Stevaux; Pascal Mertens; Jean-Yves Paquet; Jacques Godfroid; Xavier De Bolle; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.